Enhancement of dendritic cell-based vaccine potency by targeting antigen to endosomal/lysosomal compartments
- Authors
- Kang, Tae Heung; Lee, Jin Hyup; Bae, Hyun Cheol; Noh, Kyung Hee; Kim, Jin Hee; Song, Chung Kil; Shin, Byung Chul; Hung, Chien-Fu; Wu, T. -C.; Park, Jong-Sup; Kim, Tae Woo
- Issue Date
- Aug-2006
- Publisher
- ELSEVIER SCIENCE BV
- Keywords
- dendritic cell; lysosome; human papillomavirus (HPV); immunotherapy
- Citation
- IMMUNOLOGY LETTERS, v.106, no.2, pp 126 - 134
- Pages
- 9
- Journal Title
- IMMUNOLOGY LETTERS
- Volume
- 106
- Number
- 2
- Start Page
- 126
- End Page
- 134
- URI
- https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/15080
- DOI
- 10.1016/j.imlet.2006.05.004
- ISSN
- 0165-2478
1879-0542
- Abstract
- Dendritic cells (DCs) are the central players in cancer immunotherapy because of their distinct ability to prime immune responses. In previous work with DNA vaccines, we described an intracellular targeting approach that routed a nuclear/cytoplasmic antigen, human papillomavirus (HPV) type 16 E7, into the endosomal and lysosomal compartments. It does so by linking E7 with the sorting signal of lysosome-associated membrane protein 1 (Sig/LAMP-1) to enhance the presentation of E7 antigen to MHC class I-restricted CD8(+) T cells, as well as to MHC class II-restricted CD4(+) T cells. To date, the Sig/LAMP-1 targeting strategy has not been tested in the context of DC-based vaccines. This study was designed to determine whether targeting HPV-16 E7 to the endosomal/lysosomal compartment can enhance the potency of DC vaccines. In immunological studies, DC-Sig/E7/LAMP-1 dramatically increased in vitro activation and in vivo expansion of E7-specific CD4(+) and CD8(+) T cells, compared with DC-E7 and DC-No insert. More importantly, in both tumor prevention and tumor treatment assays, DC-Sig/E7/LAMP-1 generated greater anti-tumor immunity against TC-1 than DC-ET Our results demonstrate that linkage of the antigen gene to an endosomal/lysosomal targeting signal may greatly enhance the potency of DC-based vaccines. (c) 2006 Elsevier B.V. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.